Company Filing History:
1 out of 340 
1 out of 6,662 
Years Active: 1981-1987
Title: The Innovations of Bernd Herchenhan: A Pioneer in Blood Coagulation Research
Introduction: Bernd Herchenhan, an accomplished inventor based in Kirchhain, Germany, has made significant contributions to the field of blood coagulation through his innovative patents. With two active patents, his work has been instrumental in enhancing the processing of blood plasma and coagulation factors.
Latest Patents: One of Bernd Herchenhan's latest patents is titled "Process for the Manufacture of the Cold Insoluble Globulin." This patent discloses a method for isolating the cold insoluble globulin (CIG) from blood plasma concentrates containing factor VIII. His second patent, "Blood Coagulation Factors and Process for Their Manufacture," describes a process for stabilizing vital coagulation factors, including II, VIII, XIII, antithrombin III, and plasminogen against heat. The preparations developed through this process are notably free from coagulable fibrinogen, showcasing his impact on the quality and effectiveness of blood treatments.
Career Highlights: Throughout his career, Bernd Herchenhan has collaborated with notable companies in the pharmaceutical sector, including Behringwerke Aktiengesellschaft and Hoechst Aktiengesellschaft. His work at these institutions has facilitated advances in the production and stabilization of blood coagulation factors, which are critical in treating bleeding disorders.
Collaborations: Bernd has had the privilege of working alongside esteemed colleagues such as Horst Schwinn and Norbert Heimburger. These collaborations have played a crucial role in his research efforts, enabling the exchange of ideas and fostering innovation in the field of hematology.
Conclusion: In conclusion, Bernd Herchenhan's contributions to blood coagulation research reflect his commitment to improving healthcare outcomes for patients with bleeding disorders. His innovative patents and professional collaborations underscore the importance of advancements in medical technology and the continual need for research in the field of blood plasma processing.